Article

Global Parkinson’s Genetics Program (GP2) Monogenic Network Protocol: Elucidating causative gene variants in hereditary Parkinson’s disease

2022-12-05

Abstract excerpt

The Monogenic Network of the Global Parkinson’s Genetics Program (GP2) aims to create an efficient infrastructure to accelerate the identification of novel genetic causes of Parkinson’s disease (PD) and to improve our understanding of already identified genetic causes, such as reduced penetrance and variable clinical expressivity of known disease-causing variants. We aim to perform short- and long-read whole-genom...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4c7f269e-52f3-5160-891f-23d0e9ed37ad
DOI: 10.1101/2022.12.01.22282794

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Global Parkinson’s Genetics Program (GP2) Monogenic Network Protocol: Elucidating causative gene variants in hereditary Parkinson’s diseaseDOI 10.1101/2022.12.01.22282794Read

Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)Semantic proximity Read

Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications.Semantic proximity Read

The genetics of Parkinson disease.Semantic proximity Read

Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic.Semantic proximity Read

Genetics of Parkinson's disease: An introspection of its journey towards precision medicine.Semantic proximity Read

Genetics of Parkinson's Disease: From Causes to Treatment.Semantic proximity Read

Dystonia-Parkinsonism Gene Variants in Individuals with Parkinsonism and Brain Scans without Evidence for Dopaminergic Deficit (SWEDD)Semantic proximity Read

Gene4PD: a comprehensive genetic database of Parkinson's diseaseSemantic proximity Read

The Global Parkinson's Genetics Program (GP2): Advancing genetic discovery and capacity building worldwide.Semantic proximity Read

Progress in unraveling the genetic etiology of Parkinson disease in a genomic era.Semantic proximity Read

An update on the monogenic causes of Parkinson's disease: Impact on patient stratification and personalised medicine.Semantic proximity Read